Registry for people with newly diagnosed SCAD
Part of Heart & circulation clinical trials.
This is a national Swiss registry that collects information about people who have been newly diagnosed with spontaneous coronary artery dissection (SCAD) or diagnosed within the last 5 years. Your participation can help doctors better understand SCAD and improve future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have a new SCAD diagnosis, or a SCAD diagnosis within the past 5 years
- Be willing to sign the study consent form
- Not refuse or be unable to give informed consent
- Your condition must be SCAD, not caused by clogged arteries or a medical procedure
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects information from people diagnosed with spontaneous coronary artery dissection (SCAD) in the last 10 years. It aims to learn more about this rare heart condition to improve future care.
This study is a virtual registry (a way to collect and track real-world health information) for people diagnosed with SCAD at Mayo Clinic. It may help researchers better understand SCAD in groups that are often underrepresented and in urgent, recent cases.
This study looks at people admitted with a recent heart event (STEMI, NSTEMI, or unstable angina) and who were found to have SCAD on a heart scan. It may help doctors better understand and manage SCAD after these urgent events.
This study looks at genetic (inherited) causes of spontaneous coronary artery dissection (SCAD) in families. It may help researchers understand why SCAD happens and how it could be prevented or identified earlier in others.
This study looks for genetic (inherited) reasons some people develop SCAD, a sudden tear in a heart artery. It compares people with SCAD to people without it and may help doctors recognize risk and causes.
This trial studies whether taking a beta-blocker and an antiplatelet (blood thinner) helps people recover after spontaneous coronary artery dissection (SCAD). It randomizes participants to treatment combinations, aiming to see which approach works best after an event affecting heart blood flow.
Hear when a new Spontaneous Coronary Artery Dissection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.